Have a personal or library account? Click to login
A case of late diagnosis of Gaucher disease with lung involvement (case study) Cover

A case of late diagnosis of Gaucher disease with lung involvement (case study)

Open Access
|Jul 2015

References

  1. 1. Goitein, O., Elstein, D., Abrahamov, A., Hadas- Halpern, I., Melzer, E., Kerem, E. & Zimran, A.(2001). Lung involvement and enzyme replacement therapy in Gaucher's disease. Q J Med.94, 407-41510.1093/qjmed/94.8.407
  2. 2. Chen, M. & Wang, J. (2008). Gaucher Disease Review of the Literature. Arch Pathol Lab Med. 132, 851-85310.5858/2008-132-851-GDROTL
  3. 3. Koprivica, V., Stone, D.L. & Park, J.K. et al. (2000). Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher ̉s disease. Am J Hum Gen. 66(6), 1777-178610.1086/302925
  4. 4. Zhao, H., Keddache, M. & Bailey, L. et al. (2003). Gaucher s disease: identification of novel mutant alleles and genotype-phenotype relationships. Clin Genet. 64(1), 57-6410.1034/j.1399-0004.2003.00100.x
  5. 5. Amir, G. & Ron, N. (1999). Pulmonary pathology in Gaucher's disease. Hum Pathol. 30, 666-67010.1016/S0046-8177(99)90092-8
  6. 6. Beutler, E. & Grabowski, G.A. (1995). Glucosylceramide lipidoses: Gaucher disease. InScriver,C.R., Beaudet,A.L., Sly,W.S.and Valle,D., eds. The Metabolic Basis of InheritedDisease. New York:McGraw-Hill. 2641-2670
  7. 7. Di Rocco, M. et al.(2008). A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease. Haematologica. 93(8).1211-121810.3324/haematol.1237918603565
  8. 8. Kerem, E. et al. (1996). Pulmonaryfunction abnormalities in type I Gaucher disease. EurRespirJ. 9, 340-345
  9. 9. Miller, A., Brown, L.K. & Pastores, G.M. et al. (2003). Pulmonary involvement in type 1 Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease. Clin Genet. 63(5), 368-376 10.1034/j.1399-0004.2003.00060.x12752568
  10. 10. Morrel, N.W. & Wilkins M.R. (2001). Genetic and molecular mechanisms of pulmonaryhypertension. Clin Med. 1(2), 138-14510.7861/clinmedicine.1-2-138495247511333460
  11. 11. Spada, M., Chiappa, E. & Ponzone, A. (1998). Cardiac Response to Enzyme-Replacement Therapy in Gaucher's Disease.The New England Journal of Medicine.339(16), 1165-116610.1056/NEJM1998101533916159776652
  12. 12. Celik, S, Erdol, C, Baykan, M, Gokce, M, Orem, C. & Durmus, I. (2000). Mitral valve prolapse and mitral insufficiency in two siblings with Gaucher’s disease. Images Paediatr Cardiol. 4, 31-34
DOI: https://doi.org/10.1515/arsm-2015-0022 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666
Language: English
Page range: 63 - 66
Published on: Jul 29, 2015
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Doina Tofolean, Tatiana Adam, Laura Mazilu, Irinel-Raluca Parepa, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.